Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
St. Jude Children's Research Hospital
Dartmouth-Hitchcock Medical Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Universität des Saarlandes
University of Miami
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Baylor College of Medicine
Fred Hutchinson Cancer Center
Bayer
Hoffmann-La Roche
MEI Pharma, Inc.
Celgene
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Nebraska
Northside Hospital, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Genentech, Inc.
Precision BioSciences, Inc.
Medical College of Wisconsin
University of Alabama at Birmingham
Hoffmann-La Roche
SCRI Development Innovations, LLC
National Institutes of Health Clinical Center (CC)
Seagen Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
City of Hope Medical Center
SWOG Cancer Research Network
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota